Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Pyxis Oncology (PYXS) is now available.
Pyxis Oncology, Inc. has entered into a securities purchase agreement with certain investors for a private placement, aiming to raise around $50 million. The company plans to sell over 8.8 million shares and pre-funded warrants, with the closing set for February 29, 2024, and intends to use the proceeds for general corporate purposes and working capital. Additionally, they have committed to a registration rights agreement to enable the resale of these securities, ensuring they are registered with the SEC by a set deadline. The sale relies on an exemption from registration under the Securities Act, and the company has made relevant disclosures in a press release.
For a thorough assessment of PYXS stock, go to TipRanks’ Stock Analysis page.